NCT00665743View on ClinicalTrials.gov

Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Arthritis
Interventions
DRUG

PN400

naproxen 500 mg /esomeprazole 20 mg

DRUG

naproxen

naproxen 500 mg tablet

DRUG

naproxen

naproxen 500 mg

Trial Locations (1)

Unknown

Austin

Sponsors

Lead Sponsor

POZEN
All Listed Sponsors
lead

POZEN

INDUSTRY

NCT00665743 - Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations | Biotech Hunter | Biotech Hunter